{"symbol":"CI","fiscalQuarter":"Q2-2026","reportDate":"2026-07-30","reportTime":"BMO","status":"upcoming","company":{"name":"The Cigna Group","sector":"Health Care","industry":"Health Care Services"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/CI/earnings/Q2-2026","preBrief":{"companySnapshot":"The Cigna Group (CI) is a major player in the health care sector, providing health services and insurance to millions of customers. As a key provider in health care services, its performance can reflect broader trends in health care spending and insurance markets.","keyMetrics":[{"name":"Earnings Per Share (EPS)","why":"EPS is a critical measure of profitability, and investors will be looking for continued growth or stability in earnings.","consensus":"N/A"},{"name":"Revenue Growth","why":"While specific revenue estimates aren't available, growth in revenue is essential for assessing the company's market position and operational efficiency.","consensus":"N/A"}],"lastQuarterRecap":{"summary":"In Q1-2026, Cigna reported an EPS of $7.79, beating estimates by 2.18%. However, the stock saw a slight decline the following day, indicating mixed investor sentiment.","promises":[]},"wallStreetExpectations":{"summary":"Investors are cautiously optimistic ahead of Cigna's Q2-2026 earnings report, looking for continued EPS growth and insights into revenue trends.","bullCase":"If Cigna can maintain or exceed its previous EPS growth, it may signal strong operational performance and market confidence.","bearCase":"Conversely, any signs of declining profitability or revenue could lead to a negative reaction from investors, especially given recent stock volatility."},"optionsSignal":{"impliedMove":"2.99%","context":"The options market is pricing in a modest move, suggesting that investors expect limited volatility around the earnings report."},"earningsTrackRecord":[{"quarter":"Q1-2026","epsSurprise":"+2.18%","reaction":"-0.60%"},{"quarter":"Q4-2025","epsSurprise":"+2.69%","reaction":"+4.72%"},{"quarter":"Q3-2025","epsSurprise":"+1.73%","reaction":"-17.39%"},{"quarter":"Q2-2025","epsSurprise":"+0.83%","reaction":"-10.23%"},{"quarter":"Q1-2025","epsSurprise":"+5.44%","reaction":"-0.13%"}],"pivotalQuestions":[{"question":"What will the EPS be for Q2-2026, and how does it compare to previous quarters?","whyItMatters":"Given Cigna's recent performance, a strong EPS could indicate ongoing profitability, while a miss could raise concerns about future growth."},{"question":"What insights can management provide regarding revenue trends for the upcoming quarters?","whyItMatters":"Understanding revenue growth is crucial for assessing the company's market position and future performance."}],"thesisBreakLevels":{"bullTrigger":"An EPS of $8.00 or higher would confirm strong profitability and investor confidence.","bearTrigger":"An EPS below $7.50 could indicate declining performance and lead to negative market reactions.","context":"The market is debating the sustainability of Cigna's earnings growth, with recent volatility highlighting investor concerns."},"scenarioPlaybook":{"beatAndRaise":"If Cigna beats expectations and raises guidance, history suggests a potential stock increase of around 4.6%, confirming bullish sentiment.","inLineCautious":"If results are in line with expectations but management is cautious, the stock may see muted reactions as investors weigh future risks.","miss":"A miss on EPS could lead to a decline of approximately 6.7%, reflecting investor disappointment and concerns over growth."},"peerReadThroughs":[],"setupPatternInsight":{"pattern":"Prior-quarter beat + options pricing cheap in Health Care","sampleSize":30,"fadeRate":"3 of 30 (10%)","insight":"This setup has occurred 30 times across Health Care in the last 2 years. The average absolute 1-day move is 4.6%, with a raw directional average of +0.8% (modestly positive historical bias)."},"whatTheStreetIsMissing":{"thesis":"The Street may be underestimating Cigna's ability to sustain its EPS growth, especially given the company's strong historical performance.","supportingPoints":["Cigna has consistently beaten EPS estimates, with an 88% beat rate over the last eight quarters.","Options are pricing a smaller move than the historical average, suggesting a potential mispricing of volatility."],"riskToConsensus":"If Cigna's EPS comes in below $7.50, it could lead to a significant reevaluation of growth prospects."},"whatToListenFor":["Management's commentary on revenue growth projections for the next quarter.","Any updates on cost management strategies and their impact on profitability.","Insights into customer retention rates and new client acquisitions.","Details on any regulatory changes affecting the health care sector.","Updates on competitive positioning within the health care services market."],"metaDescription":"Cigna Group (CI) reports Q2 2026 earnings July 30. Investors are watching for EPS growth and revenue trends."}}